Syngene International gains on inking R&D agreement with GSK

26 Mar 2018 Evaluate

Syngene International is currently trading at Rs. 565.40, up by 5.00 points or 0.89% from its previous closing of Rs. 560.40 on the BSE.

The scrip opened at Rs. 564.00 and has touched a high and low of Rs. 571.00 and Rs. 560.00 respectively. So far 1394 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 670.00 on 24-Jan-2018 and a 52 week low of Rs. 430.00 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 572.50 and Rs. 534.30 respectively. The current market cap of the company is Rs. 11308.00 crore.

The promoters holding in the company stood at 74.46%, while Institutions and Non-Institutions held 17.82% and 7.71% respectively.

Syngene International has signed Research and Development (R&D) agreement with GSK, a science-led global healthcare company. The multiyear agreement will focus on accelerating the discovery of new drug candidates using Syngene’s discovery services platforms.

As part of the agreement, Syngene will set-up a customized discovery research laboratory to support projects across several therapeutic areas. A team of Syngene scientists will work closely with GSK’s global R&D teams on discovery research projects to identify new drug candidates with the potential to address some of the world’s most pressing healthcare needs.

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.

Syngene Internation. Share Price

715.35 10.80 (1.53%)
21-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 715.35
Sagility India 43.38
AGS Transact Tech 10.86
Just Dial 867.30
Krystal Integrated 494.80
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...